BAX and lung cancer: Administration of 20–80 μM luteolin to A549 lung cancer cells caused a dose- and time-dependent cytotoxic effect by causing cell cycle arrest and inducing apoptosis through activating JNK, increasing Bax, promoting procaspase-9 cleavage, and activating caspase-3 [51].